Search

everythinglearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Hair loss can occur when stomach cancer spreads to the scalp.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Clofazimine effectively treated ashy dermatosis in a patient.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Dutasteride may help shrink prostate cancer tumors.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.